Phase IV clinical trials

Collect information on the use of the new treatment when used in routine patient care (i.e. after a product license has been granted for marketing). For example, a new treatment may be assessed to see how it is being used in the clinic together with other effective treatments to treat a particular disease or medical condition in a select group of patients.